The global softgel capsules market size was estimated to be USD 8.73 billion in 2023 and is expected to reach at USD 19.60 billion by 2034 with a CAGR of 7.63% during the forecast period 2024-2034. Rising advancements in manufacturing technology, surge in introduction of new materials, increasing focus on development of non-gelatin-based capsules using plant-based polymers, growing launch of vegetable capsule by major market players, rising research activities for the development of oral vaccines, surge in collaborations within leading clinical-stage immunotherapy companies, increasing regulatory approvals of generic softgel capsules, and growing launch of generic softgel capsules are some of the key factors boosting the market growth.
Growing launch of generic softgel capsules is predicted to boost the market growth during the forecast period. Soft gel capsules offer several advantages compared to traditional solid oral dosage forms, and their popularity as a dosage format is growing for various reasons, including consumer preference. The development of soft gel capsule formulations aimed to conceal the unpleasant taste and odor of pharmaceuticals. For instance, in March 2023, Lotus Pharmaceutical, a prominent pharmaceutical company, unveiled the Vietnamese launch of Vinorelbine soft gel capsules 80mg and 20mg. Presently, it is the first-ever Drug Authority of Vietnam-cleared generic Vinorelbine softgel.
By type, gelatin-based/animal-based was the highest revenue-grossing segment in the global softgel capsules market in 2023 owing to increasing focus of manufacturers on developing capsules using a combination of bovine & porcine gelatin, rising product approvals by regulatory bodies, and growing launch of new products. For instance, in January 2023, Celix Pharma has unveiled its latest softgel capsules in the United Kingdom. The new offering, Bexarotene 75mg soft-gel capsules, is accessible in a packaging option that includes child-resistant HDPE bottles containing 100 capsules. Additionally, non-animal-based is predicted to grow at fastest CAGR during the forecast period owing to the rising inclination towards vegan options for medication, growing adoption by vegetarian consumers, increasing research & development activities by leading market players, and surge in collaborations within market players for the development of innovative products.
By application, vitamins & dietary supplements was the highest revenue-grossing segment in the global softgel capsules market in 2023 owing to surge in demand for these supplements in the treatment & prevention of various diseases, increasing development of vitamins, and rising launch of new products by market players. For instance, in May 2022, Solferol Softgel capsules, a Vitamin D3 medication, were launched to the Irish market by Windzor Pharma Ltd. These capsules are a budget-friendly option among the Solferol Softgel Vitamin D3 offerings. Additionally, health supplement is predicted to grow at fastest CAGR during the forecast period owing to the rising adoption of a healthy lifestyle, growing acceptance of pre & post-natal capsules, and increasing inclination towards tasteless medication.
By manufacturer, nutraceutical was the highest revenue-grossing segment in the global Softgel Capsules market in 2023 owing to rising focus on development of vitamins, minerals, & health supplements, increasing need for nutraceutical products, growing awareness of health supplements, and surge in number of production houses. Additionally, pharmaceutical companies is predicted to grow at fastest CAGR during the forecast period owing to the rising focus on manufacturing of advanced capsules, increasing launch of innovative products, and growing mergers & acquisitions within market players. For instance, in April 2022, Catalent has purchased a facility in Oxfordshire as part of its strategy to enhance biologics capabilities in the United Kingdom and throughout Europe.
North America region is anticipated for the highest revenue share during the forecast period owing to the increasing technological advancement in production, presence of major market players, rising expenditure on research & development activities, surge in number of health-conscious consumers, and growing launch of advanced products. For instance, in February 2022, in the Canadian market, ZYUS Life Sciences Inc. has released two softgel capsule options: Zylem 1:20 Softgel Capsules and Zylem 5:5 Softgel Capsules. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the presence of generic medicine manufacturers, growing demand for cost-efficient therapeutics, surge in contract manufacturing organizations, rise in personalized medicine expenditure, increasing adoption of high-tech processing to improve the production of softgels, and growing collaborations within market players. For instance, in June 2023, Lee Health Domain has introduced an innovative dietary supplement enriched with bioactive phytonutrients, known as D-Macula Soft Gel Capsules. These capsules are designed to address macular degeneration and a range of eye-related infections.
Growing launch of generic softgel capsules is predicted to boost the market growth during the forecast period. Soft gel capsules offer several advantages compared to traditional solid oral dosage forms, and their popularity as a dosage format is growing for various reasons, including consumer preference. The development of soft gel capsule formulations aimed to conceal the unpleasant taste and odor of pharmaceuticals. For instance, in March 2023, Lotus Pharmaceutical, a prominent pharmaceutical company, unveiled the Vietnamese launch of Vinorelbine soft gel capsules 80mg and 20mg. Presently, it is the first-ever Drug Authority of Vietnam-cleared generic Vinorelbine softgel.
By type, gelatin-based/animal-based was the highest revenue-grossing segment in the global softgel capsules market in 2023 owing to increasing focus of manufacturers on developing capsules using a combination of bovine & porcine gelatin, rising product approvals by regulatory bodies, and growing launch of new products. For instance, in January 2023, Celix Pharma has unveiled its latest softgel capsules in the United Kingdom. The new offering, Bexarotene 75mg soft-gel capsules, is accessible in a packaging option that includes child-resistant HDPE bottles containing 100 capsules. Additionally, non-animal-based is predicted to grow at fastest CAGR during the forecast period owing to the rising inclination towards vegan options for medication, growing adoption by vegetarian consumers, increasing research & development activities by leading market players, and surge in collaborations within market players for the development of innovative products.
By application, vitamins & dietary supplements was the highest revenue-grossing segment in the global softgel capsules market in 2023 owing to surge in demand for these supplements in the treatment & prevention of various diseases, increasing development of vitamins, and rising launch of new products by market players. For instance, in May 2022, Solferol Softgel capsules, a Vitamin D3 medication, were launched to the Irish market by Windzor Pharma Ltd. These capsules are a budget-friendly option among the Solferol Softgel Vitamin D3 offerings. Additionally, health supplement is predicted to grow at fastest CAGR during the forecast period owing to the rising adoption of a healthy lifestyle, growing acceptance of pre & post-natal capsules, and increasing inclination towards tasteless medication.
By manufacturer, nutraceutical was the highest revenue-grossing segment in the global Softgel Capsules market in 2023 owing to rising focus on development of vitamins, minerals, & health supplements, increasing need for nutraceutical products, growing awareness of health supplements, and surge in number of production houses. Additionally, pharmaceutical companies is predicted to grow at fastest CAGR during the forecast period owing to the rising focus on manufacturing of advanced capsules, increasing launch of innovative products, and growing mergers & acquisitions within market players. For instance, in April 2022, Catalent has purchased a facility in Oxfordshire as part of its strategy to enhance biologics capabilities in the United Kingdom and throughout Europe.
North America region is anticipated for the highest revenue share during the forecast period owing to the increasing technological advancement in production, presence of major market players, rising expenditure on research & development activities, surge in number of health-conscious consumers, and growing launch of advanced products. For instance, in February 2022, in the Canadian market, ZYUS Life Sciences Inc. has released two softgel capsule options: Zylem 1:20 Softgel Capsules and Zylem 5:5 Softgel Capsules. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the presence of generic medicine manufacturers, growing demand for cost-efficient therapeutics, surge in contract manufacturing organizations, rise in personalized medicine expenditure, increasing adoption of high-tech processing to improve the production of softgels, and growing collaborations within market players. For instance, in June 2023, Lee Health Domain has introduced an innovative dietary supplement enriched with bioactive phytonutrients, known as D-Macula Soft Gel Capsules. These capsules are designed to address macular degeneration and a range of eye-related infections.
Segmentation: Softgel Capsules Market Report 2022 - 2033
Softgel Capsules Market Analysis & Forecast by Type 2023 - 2034 (Revenue USD Bn)
- Non-animal based
- Gelatin/Animal based
Softgel Capsules Market Analysis & Forecast by Application 2023 - 2034 (Revenue USD Bn)
- Antibiotic & Antibacterial Drugs
- Anti-Anemic Preparations
- Anti-inflammatory Drugs
- Pregnancy
- Cough & Cold Preparations
- Vitamin & Dietary Supplement
- Antacid & Anti-flatulent Preparations
- Health Supplement
Softgel Capsules Market Analysis & Forecast by Manufacturer 2023 - 2034 (Revenue USD Bn)
- Cosmeceutical Companies
- Pharmaceutical Companies
- Nutraceutical Companies
- Contract Manufacturing Organizations
Softgel Capsules Market Analysis & Forecast by Region 2023 - 2034 (Revenue USD Bn)
North America
- U.S.
- Canada
Europe
- Germany
- France
- UK
- Spain
- Italy
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
Middle East & Africa
- South Africa
- GCC
- Rest of MEA
Table of Contents
1. Research Methodology
2. Introduction
4. Market Environment Analysis
5. Market Dynamics
7. Softgel Capsules Market: Type Estimates & Trend Analysis
8. Softgel Capsules Market: Application Estimates & Trend Analysis
9. Softgel Capsules Market: Manufacturer Estimates & Trend Analysis
10. Regional Market Analysis
11. North America Softgel Capsules Market
12. Europe Global Softgel Capsules Market
13. Asia Pacific Global Softgel Capsules Market
14. Latin America Global Softgel Capsules Market
15. MEA Global Softgel Capsules Market
16. Competitor Analysis
17. Company Profiles
Companies Mentioned
- Strides Pharma
- Capsugel
- Catalent
- Delpharm Evreux
- Patheon
- Soft Gel Technologies Inc.
- Windzor Pharma
- Sirio Pharma
- Captek
- Opticann
- Fuji Capsules Co Ltd
- Aenova
- Eurocaps
- Procaps Laboratories
- ZYUS Life Sciences Inc
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 145 |
| Published | October 2023 |
| Forecast Period | 2023 - 2034 |
| Estimated Market Value ( USD | $ 8.73 Billion |
| Forecasted Market Value ( USD | $ 19.6 Billion |
| Compound Annual Growth Rate | 7.6% |
| Regions Covered | Global |
| No. of Companies Mentioned | 15 |
